Suspension of trading
Sector Eiger BioPharmaceuticals
Stocks
EIGR
US28249U2042
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.500 USD | -.--% |
|
-.--% | - |
| 01/10/24 | Eiger BioPharmaceuticals Files for Chapter 11 Bankruptcy as Liquidation Plan Takes Effect | CI |
| 30/09/24 | Eiger BioPharmaceuticals, Inc. Went Out of Business | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -.--% | -.--% | -.--% | -.--% | -.--% | -.--% | -59.75% | -96.64% | -98.58% | 12.59M | |
| +1.38% | +6.73% | +16.71% | +13.44% | +6.10% | +2.48% | +7.78% | -12.94% | +243.53% | 49.15B | |
| +0.92% | +6.21% | +25.07% | +90.92% | +137.59% | +408.85% | +607.44% | +478.19% | - | 40.23B | |
| +1.89% | +11.06% | +14.61% | +19.50% | -8.15% | +25.75% | -7.89% | -16.90% | +209.66% | 34.55B | |
| +5.46% | +8.10% | +8.36% | -4.23% | -2.03% | +21.83% | +66.94% | -12.26% | +904.22% | 33.09B | |
| +1.20% | +2.02% | -1.31% | -5.73% | +2.45% | +9.79% | +32.43% | -19.25% | +154.37% | 25.19B | |
| +2.51% | +4.94% | +26.73% | - | - | - | - | - | - | 17.05B | |
| +2.58% | +7.24% | +25.14% | +11.89% | -0.72% | +71.03% | +132.17% | +210.14% | - | 15.92B | |
| +0.17% | +0.35% | +12.01% | +6.40% | +10.90% | +13.41% | +18.82% | -27.59% | +106.63% | 13.83B | |
| -1.14% | +7.52% | +25.83% | +51.55% | -5.03% | +14.75% | -30.83% | -19.54% | +144.99% | 13.26B | |
| +3.30% | +4.42% | +12.10% | +9.37% | +3.40% | +87.66% | +99.37% | +104.91% | +234.97% | 13.52B | |
| -0.24% | +0.18% | +42.31% | +33.31% | +20.44% | +33.19% | -13.23% | -36.98% | +152.42% | 11.04B | |
| -0.53% | +9.84% | +21.46% | +27.18% | +2.07% | +1.84% | - | - | - | 10.82B | |
| +0.70% | +8.45% | +31.98% | +32.66% | +15.65% | +46.48% | +9.72% | -38.35% | +176.94% | 11.11B | |
| +5.95% | +62.13% | +92.28% | +37.62% | +13.79% | +1,944.78% | +798.95% | +363.62% | +3,056.68% | 11.66B | |
| +0.11% | +0.17% | +68.86% | +57.59% | +76.09% | +199.89% | - | - | - | 9.96B | |
| +5.40% | -2.53% | +59.22% | +32.92% | +45.88% | +154.91% | +393.74% | +101.15% | - | 9.34B | |
| +5.73% | -2.85% | +23.42% | +2.62% | +8.07% | +587.65% | +1,746.49% | +13.01% | - | 8.88B | |
| -1.12% | +3.31% | +32.09% | +56.66% | +95.07% | +88.21% | +74.38% | +115.73% | +19.90% | 9.1B | |
| +2.48% | +2.98% | +12.36% | -2.27% | -15.29% | -21.68% | -20.22% | -27.42% | +56.54% | 8.29B | |
| Average | +1.39% | +6.45% | +27.46% | +24.81% | +21.38% | +194.25% | +226.84% | +63.46% | +412.48% | 17.3B | |
| Weighted average by Cap. | +1.51% | +6.51% | +23.35% | +26.33% | +25.07% | +164.08% | +194.21% | +86.12% | +425.69% |
- Stock Market
- Stocks
- EIGR Stock
- Sector Eiger BioPharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
